FindTrial
Sign In

Comparison of immediate and long-term efficacy of laparoscopic ISR or Miles in the treatment of ultra-low rectal cancer

Comparison of immediate and long-term efficacy of laparoscopic ISR or Miles in the treatment of ultra-low rectal cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096635
Enrollment
Unknown
Registered
2025-01-27
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal cancer

Interventions

Group ISR:NA
Group APR:NA

Sponsors

Zhangzhou Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients with primary rectal cancer diagnosed as having a tumour =5 cm from the anus undergoing ISR or Miles surgery

Exclusion criteria

Exclusion criteria: Distant metastases, open surgery, palliative surgery with preoperative combination of distant metastases, surgery with preoperative combination of acute intestinal obstruction or intestinal perforation, and other types of anastomosis-free surgery, including Hartmann's procedure and transanal local excision.

Design outcomes

Primary

MeasureTime frame
Overall survival;—

Secondary

MeasureTime frame
Disease Free Survival;Anastomotic leak;Local recurrence rate;—

Countries

China

Contacts

Public ContactGuancong Wang

Zhangzhou Affiliated Hospital of Fujian Medical University

zzsyywgc@163.com+86 133 3834 0775

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026